Karuna Therapeutics, Inc.

KRTX · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$434-$276-$144-$69
Dep. & Amort.$2$1$1$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$75$47$30$13
Change in WC$10$5$11-$16
Other Non-Cash-$38-$5$2$1
Operating Cash Flow-$386-$228-$101-$70
Investing Activities
PP&E Inv.-$3-$1-$3-$0
Net Acquisitions$4$1$3$0
Inv. Purchases-$1,521-$930-$401-$344
Inv. Sales/Matur.$1,363$345$381$255
Other Inv. Act.-$4-$1-$3-$0
Investing Cash Flow-$160-$586-$23-$90
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$488$0$0$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$483$856$278$4
Financing Cash Flow$483$856$278$4
Forex Effect$0$0$0$0
Net Chg. in Cash-$63$41$154-$156
Supplemental Information
Beg. Cash$249$207$53$209
End Cash$186$249$207$53
Free Cash Flow-$389-$229-$104-$70
Karuna Therapeutics, Inc. (KRTX) Financial Statements & Key Stats | AlphaPilot